COMMUNIQUÉS West-GlobeNewswire

NAPA’s Linda Shore-Lesserson Leads Study Recommending Concise Guidelines for Anticoagulation during Cardiopulmonary Bypass Surgery

31/01/2018 - 17:00

MELVILLE, N.Y., Jan. 31, 2018 (GLOBE NEWSWIRE) -- North American Partners in Anesthesia announced today that one of its leading anesthesiologists, Linda Shore-Lesserson, MD, served as the lead author on an innovative [...]

Catalyst Biosciences to Present Multi-Dose Subcutaneous Data for CB 2679d in Individuals with Hemophilia B in an Oral Presentation at the 11th Annual Congress of EAHAD

31/01/2018 - 16:23

Pharmacokinetics and activity after daily dosing with high potency FIX variant will be reported Conference call and webcast for investment community to be held Feb. 9, 2018 at 8:30 a.m. EST SOUTH SAN FRANCISCO, Calif., [...]

DXS International plc : Half-year Report

31/01/2018 - 16:01

DXS INTERNATIONAL PLC HALF YEAR REPORT DXS International plc ("DXS" or "the Company"), the NEX Growth Market quoted healthcare information and clinical decision support systems provider today announces its half year [...]

HCi Viocare to Develop Proprietary Blockchain Based System for Handling Client Records and Sensing-Technology Data

31/01/2018 - 15:47

GLASGOW, Scotland, Jan. 31, 2018 (GLOBE NEWSWIRE) -- HCi Viocare (OTCQB: VICA) is pleased to announce that its management, acknowledging the tremendous advantages of Blockchain technology, has decided to develop its own [...]

TOMI Environmental Solutions, Inc. Appoints Dr. Boh Soon Lim to Serve on Board of Directors

31/01/2018 - 15:30

BEVERLY HILLS, Calif., Jan. 31, 2018 (GLOBE NEWSWIRE) -- TOMI Environmental Solutions, Inc. (“TOMI”) (OTCQX:TOMZ), a global decontamination company that specializes in disinfection/decontamination sales and services, [...]

Immuron Enrols First Patients in Clinical Study of IMM-529 for Treatment of Clostridium Difficile Infection (CDI)

31/01/2018 - 15:30

Key Highlights: First patients enrolled in Immuron’s IMM-529 clinical study at Hadassah Medical Center in Israel Trial will treat 60 confirmed patients over 28 days to evaluate safety and efficacy of IMM-529 for the [...]

PositiveID’s FireflyDX Prototype Detects Flu Types; Chief Science Officer Explains Why Accurate Flu Detection at Point of Care Enables Smart Treatment Decisions in Interview with SmallCapVoice.com

31/01/2018 - 15:11

AUSTIN, Texas, Jan. 31, 2018 (GLOBE NEWSWIRE) -- SmallCapVoice.com, Inc. today announced it conducted a new audio interview with PositiveID Corporation (“PositiveID” or the “Company”) (OTC:PSID), a life sciences company [...]

Biodesix Announces PD-L1 Collaboration with Professor Fred R. Hirsch

31/01/2018 - 15:00

BOULDER, Colo., Jan. 31, 2018 (GLOBE NEWSWIRE) -- Biodesix ® announced a new collaboration agreement with PD-L1 expert Professor Fred R. Hirsch, MD, PhD, laboratory director at the Hirsch Biomarker Laboratory at the [...]

Tower One Completed Five Additional Towers

31/01/2018 - 15:00

VANCOUVER, British Columbia, Jan. 31, 2018 (GLOBE NEWSWIRE) -- Tower One Wireless Corp (CSE:TO) (OTCQB:TOWTF) (Frankfurt: 1P3N ) (the “Company ”) announces that it has completed five additional towers in Argentina. An [...]

FIT Biotech Oy: FIT Biotech Oy's Board of Directors has decided on the directed share issue without payment to the Company itself

31/01/2018 - 14:31

FIT Biotech Oy Company release January 31, 2018 at 3.30 pm EET FIT Biotech Oy's Board of Directors has decided on the directed share issue without payment to the Company itself FIT Biotech Oy's Board of Directors has [...]

BriaCell Update: Early Evidence of Efficacy and Safety of Bria-IMT™

31/01/2018 - 14:30

BERKELEY, Calif. and VANCOUVER, British Columbia, Jan. 31, 2018 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. ("BriaCell") (TSX-V: BCT ) (OTCQB:BCTXF), an immuno-oncology focused biotechnology company with a [...]

Acer Therapeutics to Present at the LEERINK Partners 7th Annual Global Healthcare Conference

31/01/2018 - 14:30

NEWTON, Mass., Jan. 31, 2018 (GLOBE NEWSWIRE) -- Acer Therapeutics Inc. (Nasdaq: ACER ), a pharmaceutical company focused on the acquisition, development and commercialization of therapies for serious rare and ultra- [...]

Diamond CBD Inc. Exhibits in Las Vegas at the Tobacco Plus Expo on January 30 - February 1

31/01/2018 - 14:30

FT LAUDERDALE, Fla., Jan. 31, 2018 (GLOBE NEWSWIRE) -- via OTC PR WIRE—PotNetwork Holding, Inc. (OTC Pink:POTN) ( http://www.potnetworkholding.com ) is pleased to announce that Diamond CBD will be exhibiting at “TPE [...]

Dermira Initiates Phase 2b Dose-Ranging Study Evaluating Lebrikizumab in Patients with Moderate-to-Severe Atopic Dermatitis

31/01/2018 - 14:30

Study expected to enroll approximately 275 patients Topline results expected in the first half of 2019 TREBLE Phase 2 proof-of-concept results published in the Journal of the American Academy of Dermatology MENLO PARK, [...]

Hemispherx’s Ampligen Highlighted in Review of Role of TLR3 Agonist Support for “Universal” Flu Immunization Development Programs

31/01/2018 - 14:30

BANFF, Alberta, Jan. 31, 2018 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc. (NYSE American:HEB) said William Mitchell, MD, PhD*, Professor of Pathology, Microbiology & Immunology at Vanderbilt University, provided [...]

Skyline Medical Projects 100 STREAMWAY System Sales in the U.S. in 2018

31/01/2018 - 14:30

MINNEAPOLIS, Jan. 31, 2018 (GLOBE NEWSWIRE) -- Skyline Medical Inc. (NASDAQ: SKLN ) (“Skyline” or the “Company”), is pleased to announce that it currently projects sales of approximately 100 STREAMWAY Systems in 2018. [...]

Profound Medical Corp. Announces Completion of Patient Enrollment in TACT Pivotal Clinical Trial

31/01/2018 - 14:00

TORONTO, Jan. 31, 2018 (GLOBE NEWSWIRE) -- Profound Medical Corp. (TSX-V: PRN ) (OTCQX:PRFMF) (“Profound” or the “Company”), the only company to offer a therapeutic platform that provides the precision of real-time MR [...]

Quotient Limited to Participate in the LEERINK Partners 7th Annual Global Healthcare Conference

31/01/2018 - 14:00

JERSEY, Channel Islands, Jan. 31, 2018 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ: QTNT ), a commercial-stage diagnostics company, today announced that the Company's Chairman and Chief Executive Officer, Paul Cowan, [...]

Paratek Pharmaceuticals to Present at LEERINK Partners 7th Annual Global Healthcare Conference

31/01/2018 - 14:00

BOSTON, Jan. 31, 2018 (GLOBE NEWSWIRE) -- Paratek Pharmaceuticals, Inc. (Nasdaq: PRTK ), announced today that its President, Chief Operating Officer and Chief Medical Officer, Evan Loh, MD and Chief Commercial Officer [...]